tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Zelira Therapeutics’ ZLT-L-007 Shows Promising Results in Diabetic Neuropathy Study
PremiumCompany AnnouncementsZelira Therapeutics’ ZLT-L-007 Shows Promising Results in Diabetic Neuropathy Study
4M ago
Zelira Therapeutics Strengthens Financial Position and Advances Product Development
Premium
Company Announcements
Zelira Therapeutics Strengthens Financial Position and Advances Product Development
5M ago
Zelira Therapeutics Converts $3.25M Notes to Equity, Advances Autism Treatment Trials
Premium
Company Announcements
Zelira Therapeutics Converts $3.25M Notes to Equity, Advances Autism Treatment Trials
5M ago
Zelira Therapeutics Secures $1 Million ATM Funding for Growth
PremiumCompany AnnouncementsZelira Therapeutics Secures $1 Million ATM Funding for Growth
6M ago
Zelira Therapeutics Advances Autism Drug Program with FDA Support and Patent Secures
Premium
Company Announcements
Zelira Therapeutics Advances Autism Drug Program with FDA Support and Patent Secures
7M ago
Zelira Therapeutics Secures $1.15M R&D Tax Incentive Refund to Bolster Operations
Premium
Company Announcements
Zelira Therapeutics Secures $1.15M R&D Tax Incentive Refund to Bolster Operations
8M ago
Zelira Therapeutics Issues 3.5 Million Convertible Notes
PremiumCompany AnnouncementsZelira Therapeutics Issues 3.5 Million Convertible Notes
10M ago
Zelira Therapeutics Unveils Growth Plans at Investment Conference
Premium
Company Announcements
Zelira Therapeutics Unveils Growth Plans at Investment Conference
11M ago
Zelira Therapeutics Secures Shareholder Support at AGM
Premium
Company Announcements
Zelira Therapeutics Secures Shareholder Support at AGM
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100